US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Nexalin Technology, Inc.

1.29

+0.10008.40%

Post-market: 1.290.00000.00%19:40 EDT

Volume:116.58K

Turnover:146.04K

Market Cap:22.16M

PE:-1.61

High:1.29

Open:1.20

Low:1.17

Close:1.19

Loading ...

Overview Company News Filings

Nexalin Technology Q1 EPS $(0.15) Misses $(0.10) Estimate, Sales $41.02K Beat $35.00K Estimate

Nexalin Technology Inc. Announces Upcoming Alzheimer's Clinical Trials Featuring Advanced Brain Modulation Technology

Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering

THOMSON REUTERS

Press Release: Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering

Nexalin Shares Fall After Pricing of $5 Million Public Offering

MT Newswires Live

BRIEF-Nexalin Technology Prices $5 Million Public Offering

Nexalin Technology Inc - Prices Public Offering of 3.9 Mln Shares at $1.30 per Share

THOMSON REUTERS

Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock

THOMSON REUTERS

Press Release: Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock

BRIEF-Nexalin Technology Says Q-Submission To Facilitate Dialogue With FDA On Clinical Trial Design

Nexalin Technology Inc. Advances Gen-2 SYNC System with FDA Q-Submission for Alzheimer's and Dementia Clinical Trials

Nexalin Technology Inc - Q-Submission to Facilitate Dialogue With FDA on Clinical Trial Design

THOMSON REUTERS

Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 Sync Following Encouraging Data and Preliminary FDA Feedback

THOMSON REUTERS

Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback

BRIEF-Nexalin Technology Receives IRB Approval In Brazil And Begins Clinical Trial For Anxiety And Insomnia

Nexalin Technology Receives Irb Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia

THOMSON REUTERS

Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia

BRIEF-Nexalin Technology Inc May Offer, Sell Up To $50 Mln Of Common Stock From Time To Time In One Or More Offerings

Nexalin Technology files $50M common stock offering

Nexalin Technology Inc: May Offer, Sell up to $50 Mln of Common Stock From Time to Time in One or More Offerings

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/NXL/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NXL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXL\",,,,,undefined,":{"symbol":"NXL","market":"US","secType":"STK","nameCN":"Nexalin Technology, Inc.","latestPrice":1.29,"timestamp":1749240000000,"preClose":1.19,"halted":0,"volume":116576,"hourTrading":{"tag":"盘后","latestPrice":1.29,"preClose":1.29,"latestTime":"19:40 EDT","volume":3804,"amount":4917.2998,"timestamp":1749253224394},"delay":0,"floatShares":14686700,"shares":17177929,"eps":-0.80071,"marketStatus":"Market Closed","change":0.1,"latestTime":"06-06 16:00:00 EDT","open":1.2008,"high":1.29,"low":1.1701,"amount":146044.9672576,"amplitude":0.100756,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.80071,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1749456000000},"marketStatusCode":7,"adr":0,"listingDate":1663300800000,"exchange":"NASDAQ","adjPreClose":1.19,"preHourTrading":{"tag":"盘前","latestPrice":1.1553,"preClose":1.186,"latestTime":"08:39 EDT","volume":200,"amount":231.06,"timestamp":1749213599453},"postHourTrading":{"tag":"盘后","latestPrice":1.29,"preClose":1.29,"latestTime":"19:40 EDT","volume":3804,"amount":4917.2998,"timestamp":1749253224394},"volumeRatio":1.3688091490302692},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NXL\",,,,,undefined,":{"symbol":"NXL","floatShares":14686700,"roa":"-189.48%","roe":"-367.74%","lyrEps":-0.825452,"volumeRatio":1.3688091490302692,"shares":17177929,"dividePrice":0,"high":1.29,"amplitude":0.100756,"preClose":1.19,"low":1.1701,"week52Low":0.53,"pbRate":"9.53","psRate":"169.07","week52High":4.4899,"institutionHeld":0,"latestPrice":1.29,"eps":-0.80071,"divideRate":0,"volume":116576,"delay":0,"ttmEps":-0.80071,"open":1.2008,"prevYearClose":2.76,"prevWeekClose":1.19,"prevMonthClose":1.19,"prevQuarterClose":1.95,"fiveDayClose":1.19,"twentyDayClose":1.22,"sixtyDayClose":2.25},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"NXL\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2535014033","title":"Nexalin Technology Q1 EPS $(0.15) Misses $(0.10) Estimate, Sales $41.02K Beat $35.00K Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2535014033","media":"Benzinga","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535014033?lang=en_us&edition=fundamental","pubTime":"2025-05-14 05:54","pubTimestamp":1747173282,"startTime":"0","endTime":"0","summary":"Nexalin Technology (NASDAQ:NXL) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.10) by 50 percent. This is a 7.14 percent decrease over losses of $(0.14) per share from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/25/05/45394246/nexalin-technology-q1-eps-0-15-misses-0-10-estimate-sales-41-02k-beat-35-00k-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL"],"gpt_icon":0},{"id":"2535778664","title":"Nexalin Technology Inc. Announces Upcoming Alzheimer's Clinical Trials Featuring Advanced Brain Modulation Technology","url":"https://stock-news.laohu8.com/highlight/detail?id=2535778664","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2535778664?lang=en_us&edition=fundamental","pubTime":"2025-05-13 20:30","pubTimestamp":1747139420,"startTime":"0","endTime":"0","summary":"Nexalin Technology Inc. has announced plans to initiate new Alzheimer's-focused clinical studies in the third quarter of 2025. The studies will incorporate cognitive testing, imaging biomarkers, and MEG-guided metrics to assess the efficacy of their Deep Intracranial Frequency Stimulation  technology in treating Alzheimer's disease. This initiative follows the reconstitution of Nexalin's Scientific Advisory Board with the appointment of renowned experts Dr. Mingxiong Huang, Dr. David Owens, and Dr. Abe Scheer, who will guide the company's scientific direction and clinical strategy. The move underscores Nexalin's commitment to advancing non-invasive neuromodulation therapies and addressing critical public health challenges related to neurodegenerative diseases.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250513:nNDL7lZFPD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4588","LU2095319765.USD","NXL","BK4112","IE00BGHQF748.EUR","BK4585","LU2210149790.SGD","IE00B3QW5Z07.USD","NDAQ","BK4082","IE00BKPKM429.USD","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2533966532","title":"Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2533966532","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533966532?lang=en_us&edition=fundamental","pubTime":"2025-05-07 02:40","pubTimestamp":1746556825,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nTUA9NLP5G:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NXL","NXLIW"],"gpt_icon":0},{"id":"2533665371","title":"Press Release: Nexalin Technology Announces Closing of Previously Announced $5.0 Million Underwritten Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2533665371","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533665371?lang=en_us&edition=fundamental","pubTime":"2025-05-07 02:40","pubTimestamp":1746556800,"startTime":"0","endTime":"0","summary":"HOUSTON, May 06, 2025  --  Nexalin Technology, Inc.  , the leader in Deep Intracranial Frequency Stimulation  of the brain, today announced the closing of its previously announced underwritten public offering of 3,850,000 shares of its common stock at a public offering price of $1.30 per share. The gross proceeds from the offering to Nexalin were approximately $5.0 million, before deducting underwriting discounts and commissions and other offering expenses.Maxim Group LLC acted as sole book-running manager for the offering.This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or other jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of any such state or other jurisdiction.This press release contains forward-looking statements that are based on the Company's beliefs and assumpt","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","BK4588","BK4555","BK4604","TM","BK4099","NXL","BK4585","03160"],"gpt_icon":0},{"id":"2533155982","title":"Nexalin Shares Fall After Pricing of $5 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2533155982","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533155982?lang=en_us&edition=fundamental","pubTime":"2025-05-06 02:21","pubTimestamp":1746469274,"startTime":"0","endTime":"0","summary":"Nexalin Technology  shares fell over 23% in recent trading Monday after the company priced its underwritten public offering of 3.85 million shares at $1.30 per share.The stock closed at $1.79 Friday.Nexalin said it has granted its underwriters a 45-day option to purchase up to 577,500 additional shares. Maxim Group is the book-running manager for the offering set to close Tuesday.The company said it intends to use the net proceeds for working capital and other general corporate purposes.Price: 1.37, Change: -0.42, Percent Change: -23.46","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NXL.AU","NXL","BK4082","BK7016"],"gpt_icon":0},{"id":"2533586707","title":"BRIEF-Nexalin Technology Prices $5 Million Public Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2533586707","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533586707?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:21","pubTimestamp":1746447714,"startTime":"0","endTime":"0","summary":"BRIEF-Nexalin Technology Prices $5 Million Public Offering May 5 (Reuters) - Nexalin Technology Inc NXL.O:NEXALIN TECHNOLOGY ANNOUNCES PRICING OF $5.0 MILLION PUBLIC OFFERING OF COMMON STOCKNEXALIN TE","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUA7MRDBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL","BK4082","NXLIW"],"gpt_icon":0},{"id":"2533867755","title":"Nexalin Technology Inc - Prices Public Offering of 3.9 Mln Shares at $1.30 per Share","url":"https://stock-news.laohu8.com/highlight/detail?id=2533867755","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533867755?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:20","pubTimestamp":1746447619,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUA7MRDBH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXLIW","BK4082","NXL"],"gpt_icon":0},{"id":"2533712586","title":"Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2533712586","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533712586?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:20","pubTimestamp":1746447619,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250505:nTUA7MRDBH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXLIW","NXL","BK4082"],"gpt_icon":0},{"id":"2533779586","title":"Press Release: Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2533779586","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2533779586?lang=en_us&edition=fundamental","pubTime":"2025-05-05 20:20","pubTimestamp":1746447600,"startTime":"0","endTime":"0","summary":"HOUSTON, May 05, 2025  -- Nexalin Technology, Inc.  , the leader in Deep Intracranial Frequency Stimulation  of the brain, today announced the pricing of an underwritten public offering of 3,850,000 shares of its common stock at a price to the public of $1.30 per share. The gross proceeds from the offering to Nexalin are expected to be approximately $5.0 million, before deducting underwriting discounts and commissions and other offering expenses. The offering is expected to close on or about May 6, 2025, subject to customary closing conditions. In addition, Nexalin has granted the underwriters a 45-day option to purchase up to 577,500 additional shares of common stock at the public offering price, less the underwriting discounts and commissions.Maxim Group LLC is acting as the sole book-running manager for the offering.Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All Nexalin's products are believed ","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","TM","03160","BK4082","BK4585","BK4604","BK4588","BK4555","NXL"],"gpt_icon":0},{"id":"2532000413","title":"BRIEF-Nexalin Technology Says Q-Submission To Facilitate Dialogue With FDA On Clinical Trial Design","url":"https://stock-news.laohu8.com/highlight/detail?id=2532000413","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532000413?lang=en_us&edition=fundamental","pubTime":"2025-05-02 00:26","pubTimestamp":1746116794,"startTime":"0","endTime":"0","summary":"BRIEF-Nexalin Technology Says Q-Submission To Facilitate Dialogue With FDA On Clinical Trial DesignMay 1 (Reuters) - Nexalin Technology Inc NXL.O:NEXALIN TECHNOLOGY INITIATES FDA Q-SUBMISSION PROCESS ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nTUABNDGG2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL","BK4082","NXLIW"],"gpt_icon":0},{"id":"2532001319","title":"Nexalin Technology Inc. Advances Gen-2 SYNC System with FDA Q-Submission for Alzheimer's and Dementia Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2532001319","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532001319?lang=en_us&edition=fundamental","pubTime":"2025-05-01 22:30","pubTimestamp":1746109814,"startTime":"0","endTime":"0","summary":"Nexalin Technology, Inc.  has announced its intention to initiate a Q-Submission to the U.S. Food and Drug Administration  related to its Gen-2 SYNC system. This regulatory process aims to facilitate dialogue with the FDA regarding the clinical trial design for treating Alzheimer's disease, dementia, and mild cognitive impairment . The company's decision follows encouraging internal data and preliminary feedback from the FDA. Nexalin's Gen-2 SYNC system, featuring technical enhancements and a proprietary 15 milliamp advanced waveform, is positioned as a promising non-invasive therapeutic option for cognitive conditions. The company views this regulatory milestone as a critical step towards advancing its neuromodulation platform for cognitive and neuropsychiatric disorders.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nNDL1XlRyH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2210150020.SGD","BK4588","LU2095319765.USD","NXL","BK4112","IE00BGHQF748.EUR","BK4585","LU2210149790.SGD","IE00B3QW5Z07.USD","NDAQ","BK4082","IE00BKPKM429.USD","IE00B64PRP62.GBP"],"gpt_icon":0},{"id":"2532462006","title":"Nexalin Technology Inc - Q-Submission to Facilitate Dialogue With FDA on Clinical Trial Design","url":"https://stock-news.laohu8.com/highlight/detail?id=2532462006","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532462006?lang=en_us&edition=fundamental","pubTime":"2025-05-01 22:30","pubTimestamp":1746109801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nTUABNDGG2:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NXL"],"gpt_icon":0},{"id":"2532006464","title":"Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 Sync Following Encouraging Data and Preliminary FDA Feedback","url":"https://stock-news.laohu8.com/highlight/detail?id=2532006464","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532006464?lang=en_us&edition=fundamental","pubTime":"2025-05-01 22:30","pubTimestamp":1746109801,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250501:nTUABNDGG2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NXLIW","NXL"],"gpt_icon":0},{"id":"2532006075","title":"Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback","url":"https://stock-news.laohu8.com/highlight/detail?id=2532006075","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2532006075?lang=en_us&edition=fundamental","pubTime":"2025-05-01 22:30","pubTimestamp":1746109800,"startTime":"0","endTime":"0","summary":"Company initiates formal regulatory engagement on trial design for Alzheimer’s, dementia, and MCI indications. HOUSTON, TX, May 01, 2025  -- Nexalin Technology, Inc.  , today announced that it plans to submit a Q-Submission  to the U.S. Food and Drug Administration  related to its Gen-2 SYNC system. This regulatory milestone is intended to facilitate structured dialogue with the FDA regarding clinical trial design for the treatment of Alzheimer’s disease, dementia, and mild cognitive impairment .Nexalin designs and develops innovative neurostimulation products to uniquely help combat the ongoing global mental health epidemic. All of Nexalin’s products are non-invasive and undetectable to the human body and are developed to provide relief to those afflicted with mental health issues. Nexalin utilizes bioelectronic medical technology to treat mental health issues. Nexalin believes its neurostimulation medical devices can penetrate structures deep in the mid-brain that are associated with","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nexalin-technology-initiates-fda-q-143000222.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["MCI","LU2286300806.USD","NXLIW","BK4082","GEN","BK4588","BK4585","BK4097","NXL"],"gpt_icon":0},{"id":"2529980998","title":"BRIEF-Nexalin Technology Receives IRB Approval In Brazil And Begins Clinical Trial For Anxiety And Insomnia","url":"https://stock-news.laohu8.com/highlight/detail?id=2529980998","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529980998?lang=en_us&edition=fundamental","pubTime":"2025-04-24 21:05","pubTimestamp":1745499909,"startTime":"0","endTime":"0","summary":"BRIEF-Nexalin Technology Receives IRB Approval In Brazil And Begins Clinical Trial For Anxiety And InsomniaApril 24  - Nexalin Technology Inc NXL.O:NEXALIN TECHNOLOGY RECEIVES IRB APPROVAL IN BRAZIL AND  BEGINS CLINICAL TRIAL FOR ANXIETY AND INSOMNIASource text: ID:nGNEh93Further company coverage: NXL.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nFWN3R236I:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","NXL"],"gpt_icon":0},{"id":"2529877379","title":"Nexalin Technology Receives Irb Approval in Brazil and  Begins Clinical Trial for Anxiety and Insomnia","url":"https://stock-news.laohu8.com/highlight/detail?id=2529877379","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529877379?lang=en_us&edition=fundamental","pubTime":"2025-04-24 21:00","pubTimestamp":1745499602,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250424:nTUA8ZBQVY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["NXL","NXLIW","BK4082"],"gpt_icon":0},{"id":"2529980941","title":"Nexalin Technology Receives IRB Approval in Brazil and  Begins Clinical Trial for Anxiety and Insomnia","url":"https://stock-news.laohu8.com/highlight/detail?id=2529980941","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529980941?lang=en_us&edition=fundamental","pubTime":"2025-04-24 21:00","pubTimestamp":1745499600,"startTime":"0","endTime":"0","summary":"HOUSTON, TX, April 24, 2025  -- Nexalin Technology, Inc.   the leader in Deep Intracranial Frequency Stimulation  of the brain, today announced that its proprietary Gen-2 neurostimulation device has received institutional review board  approval in Brazil for a new clinical trial evaluating its use in the treatment of anxiety disorders and chronic insomnia. The study will be conducted at the Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de So Paulo , one of Latin America’s most prestigious psychiatric research institutions.The first Nexalin device has been shipped to So Paulo, Brazil, with additional units and single-use disposable electrodes scheduled for delivery in the coming days. These shipments support the launch of a Phase II clinical trial in adult patients suffering from anxiety and insomnia—two conditions that are frequently comorbid and significantly affect quality of life.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/nexalin-technology-receives-irb-approval-130000945.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["NXLIW","BK4082","NXL"],"gpt_icon":0},{"id":"2529661094","title":"BRIEF-Nexalin Technology Inc May Offer, Sell Up To $50 Mln Of Common Stock From Time To Time In One Or More Offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=2529661094","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529661094?lang=en_us&edition=fundamental","pubTime":"2025-04-24 05:58","pubTimestamp":1745445524,"startTime":"0","endTime":"0","summary":"BRIEF-Nexalin Technology Inc May Offer, Sell Up To $50 Mln Of Common Stock From Time To Time In One Or More OfferingsApril 23  - Nexalin Technology Inc NXL.O:NEXALIN TECHNOLOGY INC: MAY OFFER, SELL UP TO $50 MILLION OF COMMON STOCK FROM TIME TO TIME IN ONE OR MORE OFFERINGSSource text: [ID:n0001829126-25-002877]Further company coverage: NXL.O ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nFWN3R123A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["NXL","BK4082"],"gpt_icon":0},{"id":"2529866153","title":"Nexalin Technology files $50M common stock offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2529866153","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529866153?lang=en_us&edition=fundamental","pubTime":"2025-04-24 05:35","pubTimestamp":1745444145,"startTime":"0","endTime":"0","summary":"17:30 EDT Nexalin Technology (NXL) files $50M common stock offering Published first on TheFly – the ultimate source for real-time, market-moving br...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/nexalin-technology-files-50m-common-stock-offering?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/nexalin-technology-files-50m-common-stock-offering?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NXL","BK4082"],"gpt_icon":0},{"id":"2529669744","title":"Nexalin Technology Inc: May Offer, Sell up to $50 Mln of Common Stock From Time to Time in One or More Offerings","url":"https://stock-news.laohu8.com/highlight/detail?id=2529669744","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2529669744?lang=en_us&edition=fundamental","pubTime":"2025-04-24 05:29","pubTimestamp":1745443768,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250423:nFWN3R123A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","NXL"],"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":53,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NXL\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NXL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NXL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":1,"updateTime":1742875200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/NXL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"NXL","date":"2025-06-06","current":-2.389627,"percent":0.625369,"low":-11.123806,"twenty":-4.933777,"median":-2.885538,"eighty":-1.247409,"high":-0.46259,"avg":-3.359365,"sd":2.445938,"marketCap":20441735},"quantilePoints":[{"date":"2022-09-16","current":-5.073734,"twenty":-6.382342,"median":-6.382342,"eighty":-5.597177,"marketCap":16379912},{"date":"2022-09-23","current":-2.773641,"twenty":-5.858899,"median":-3.709464,"eighty":-3.008161,"marketCap":8954352},{"date":"2022-09-30","current":-2.435392,"twenty":-4.568616,"median":-2.908941,"eighty":-2.579712,"marketCap":7862357},{"date":"2022-10-07","current":-2.503042,"twenty":-3.729758,"median":-2.593242,"eighty":-2.489512,"marketCap":8080756},{"date":"2022-10-14","current":-2.886391,"twenty":-3.427589,"median":-2.773641,"eighty":-2.503042,"marketCap":9318350},{"date":"2022-10-21","current":-3.044241,"twenty":-3.11189,"median":-2.852566,"eighty":-2.512062,"marketCap":9827947},{"date":"2022-10-28","current":-3.333782,"twenty":-3.13895,"median":-2.908715,"eighty":-2.525592,"marketCap":10762694},{"date":"2022-11-04","current":-3.630539,"twenty":-3.342712,"median":-2.948628,"eighty":-2.543632,"marketCap":11720737},{"date":"2022-11-11","current":-8.471203,"twenty":-3.677893,"median":-2.954041,"eighty":-2.579712,"marketCap":13249529},{"date":"2022-11-18","current":-8.378112,"twenty":-4.631756,"median":-3.015602,"eighty":-2.593242,"marketCap":13103929},{"date":"2022-11-25","current":-10.658821,"twenty":-7.755915,"median":-3.13444,"eighty":-2.629322,"marketCap":16671110},{"date":"2022-12-02","current":-10.938092,"twenty":-8.471203,"median":-3.31484,"eighty":-2.782661,"marketCap":17107908},{"date":"2022-12-09","current":-10.333006,"twenty":-9.802392,"median":-3.467052,"eighty":-2.818741,"marketCap":16161513},{"date":"2022-12-16","current":-3.444335,"twenty":-9.802392,"median":-3.607989,"eighty":-2.818741,"marketCap":5387171},{"date":"2022-12-23","current":-3.63517,"twenty":-9.44865,"median":-3.619264,"eighty":-2.832271,"marketCap":5685649},{"date":"2022-12-30","current":-3.486225,"twenty":-9.076288,"median":-3.596714,"eighty":-2.886391,"marketCap":5452690},{"date":"2023-01-06","current":-3.504843,"twenty":-8.852872,"median":-3.596714,"eighty":-2.90425,"marketCap":5481810},{"date":"2023-01-13","current":-4.326829,"twenty":-8.648074,"median":-3.630539,"eighty":-2.908896,"marketCap":6767451},{"date":"2023-01-20","current":-5.301949,"twenty":-8.527057,"median":-3.653322,"eighty":-2.929642,"marketCap":8292603},{"date":"2023-01-27","current":-5.205601,"twenty":-8.471203,"median":-3.704665,"eighty":-2.949666,"marketCap":8141908},{"date":"2023-02-03","current":-5.026867,"twenty":-8.415348,"median":-3.810938,"eighty":-2.953951,"marketCap":7862357},{"date":"2023-02-10","current":-5.678498,"twenty":-8.378112,"median":-3.923688,"eighty":-2.954041,"marketCap":8881552},{"date":"2023-02-17","current":-5.119958,"twenty":-8.21083,"median":-4.305419,"eighty":-2.967571,"marketCap":8007957},{"date":"2023-02-24","current":-4.087122,"twenty":-7.763997,"median":-4.305419,"eighty":-2.98074,"marketCap":6392533},{"date":"2023-03-03","current":-4.468326,"twenty":-6.909555,"median":-4.267252,"eighty":-3.009875,"marketCap":6988762},{"date":"2023-03-10","current":-4.747597,"twenty":-6.382342,"median":-4.328691,"eighty":-3.071301,"marketCap":7425560},{"date":"2023-03-17","current":-5.026867,"twenty":-6.100804,"median":-4.480661,"eighty":-3.12993,"marketCap":7862357},{"date":"2023-03-24","current":-4.794607,"twenty":-5.641262,"median":-4.519061,"eighty":-3.175481,"marketCap":7499087},{"date":"2023-03-31","current":-3.433381,"twenty":-5.576099,"median":-4.480661,"eighty":-3.247866,"marketCap":5829249},{"date":"2023-04-06","current":-3.31965,"twenty":-5.510936,"median":-4.366393,"eighty":-3.315802,"marketCap":5636155},{"date":"2023-04-14","current":-3.60505,"twenty":-5.306138,"median":-4.305419,"eighty":-3.315802,"marketCap":6120712},{"date":"2023-04-21","current":-3.347546,"twenty":-5.306138,"median":-4.128082,"eighty":-3.315802,"marketCap":5683518},{"date":"2023-04-28","current":-3.562562,"twenty":-5.306138,"median":-4.003341,"eighty":-3.322476,"marketCap":6048575},{"date":"2023-05-05","current":-3.733802,"twenty":-5.3053,"median":-3.915598,"eighty":-3.335677,"marketCap":6339308},{"date":"2023-05-12","current":-3.01616,"twenty":-5.282679,"median":-3.810938,"eighty":-3.335677,"marketCap":6192120},{"date":"2023-05-19","current":-2.818112,"twenty":-5.188472,"median":-3.732836,"eighty":-3.214916,"marketCap":5785530},{"date":"2023-05-26","current":-2.767002,"twenty":-5.119958,"median":-3.715347,"eighty":-3.089151,"marketCap":5680603},{"date":"2023-06-02","current":-3.273482,"twenty":-5.119958,"median":-3.699867,"eighty":-3.044241,"marketCap":6720396},{"date":"2023-06-09","current":-3.251121,"twenty":-5.119958,"median":-3.681736,"eighty":-3.052363,"marketCap":6674490},{"date":"2023-06-16","current":-3.263544,"twenty":-5.073734,"median":-3.647538,"eighty":-3.044241,"marketCap":6699993},{"date":"2023-06-23","current":-3.023969,"twenty":-5.073476,"median":-3.630539,"eighty":-3.042316,"marketCap":6208150},{"date":"2023-06-30","current":-3.229471,"twenty":-5.073412,"median":-3.607989,"eighty":-3.049114,"marketCap":6630042},{"date":"2023-07-07","current":-3.28271,"twenty":-5.073412,"median":-3.60505,"eighty":-3.06656,"marketCap":6739341},{"date":"2023-07-14","current":-2.838342,"twenty":-5.054794,"median":-3.60505,"eighty":-3.038466,"marketCap":5827063},{"date":"2023-07-21","current":-2.875965,"twenty":-5.026867,"median":-3.603763,"eighty":-3.000615,"marketCap":5904301},{"date":"2023-07-28","current":-2.789363,"twenty":-5.008249,"median":-3.588807,"eighty":-2.957877,"marketCap":5726509},{"date":"2023-08-04","current":-2.594508,"twenty":-4.961704,"median":-3.5728,"eighty":-2.942778,"marketCap":5326476},{"date":"2023-08-11","current":-2.284658,"twenty":-4.933777,"median":-3.560201,"eighty":-2.908805,"marketCap":4690359},{"date":"2023-08-18","current":-1.816454,"twenty":-4.933777,"median":-3.537425,"eighty":-2.875326,"marketCap":4424754},{"date":"2023-08-25","current":-1.282203,"twenty":-4.933777,"median":-3.497652,"eighty":-2.827127,"marketCap":3123356},{"date":"2023-09-01","current":-1.360051,"twenty":-4.915159,"median":-3.486225,"eighty":-2.818364,"marketCap":3312988},{"date":"2023-09-08","current":-1.283424,"twenty":-4.887232,"median":-3.444801,"eighty":-2.803631,"marketCap":3126330},{"date":"2023-09-15","current":-1.312732,"twenty":-4.887232,"median":-3.433381,"eighty":-2.788795,"marketCap":3197721},{"date":"2023-09-22","current":-1.312732,"twenty":-4.887139,"median":-3.39261,"eighty":-2.768493,"marketCap":3197721},{"date":"2023-09-29","current":-1.472702,"twenty":-4.877551,"median":-3.360231,"eighty":-2.700987,"marketCap":3587397},{"date":"2023-10-06","current":-1.190617,"twenty":-4.840687,"median":-3.343255,"eighty":-2.636674,"marketCap":2900259},{"date":"2023-10-13","current":-1.330438,"twenty":-4.831471,"median":-3.336304,"eighty":-2.575202,"marketCap":3240853},{"date":"2023-10-20","current":-1.010498,"twenty":-4.785205,"median":-3.31965,"eighty":-2.503042,"marketCap":2461502},{"date":"2023-10-27","current":-1.037974,"twenty":-4.766401,"median":-3.31484,"eighty":-2.480492,"marketCap":2528431},{"date":"2023-11-03","current":-0.924102,"twenty":-4.747597,"median":-3.278273,"eighty":-2.375098,"marketCap":2251047},{"date":"2023-11-10","current":-1.098726,"twenty":-4.736426,"median":-3.263544,"eighty":-1.867376,"marketCap":2676418},{"date":"2023-11-17","current":-0.465824,"twenty":-4.684017,"median":-3.249346,"eighty":-1.703376,"marketCap":2141729},{"date":"2023-11-24","current":-0.526479,"twenty":-4.652366,"median":-3.216344,"eighty":-1.47551,"marketCap":2420600},{"date":"2023-12-01","current":-0.630966,"twenty":-4.633097,"median":-3.194333,"eighty":-1.433259,"marketCap":2901002},{"date":"2023-12-08","current":-0.64714,"twenty":-4.607776,"median":-3.192381,"eighty":-1.383558,"marketCap":2975368},{"date":"2023-12-15","current":-0.622393,"twenty":-4.601166,"median":-3.165229,"eighty":-1.337643,"marketCap":2861589},{"date":"2023-12-22","current":-0.483617,"twenty":-4.588878,"median":-3.140169,"eighty":-1.312732,"marketCap":2223532},{"date":"2023-12-29","current":-0.650213,"twenty":-4.584689,"median":-3.123348,"eighty":-1.283424,"marketCap":2989497},{"date":"2024-01-05","current":-0.630804,"twenty":-4.5602,"median":-3.103112,"eighty":-1.276097,"marketCap":2900259},{"date":"2024-01-12","current":-0.750495,"twenty":-4.528986,"median":-3.052363,"eighty":-1.223467,"marketCap":3450564},{"date":"2024-01-19","current":-0.727851,"twenty":-4.517385,"median":-3.034616,"eighty":-1.19715,"marketCap":3346452},{"date":"2024-01-26","current":-0.528905,"twenty":-4.506122,"median":-3.016515,"eighty":-1.180419,"marketCap":2431755},{"date":"2024-02-02","current":-0.627407,"twenty":-4.483128,"median":-2.986964,"eighty":-1.132613,"marketCap":2884642},{"date":"2024-02-09","current":-0.490248,"twenty":-4.442634,"median":-2.958836,"eighty":-1.026617,"marketCap":2254021},{"date":"2024-02-16","current":-0.514672,"twenty":-4.373933,"median":-2.953815,"eighty":-0.975085,"marketCap":2366314},{"date":"2024-02-23","current":-0.501408,"twenty":-4.328319,"median":-2.942336,"eighty":-0.95921,"marketCap":2305334},{"date":"2024-03-01","current":-0.501733,"twenty":-4.322547,"median":-2.909667,"eighty":-0.893084,"marketCap":2306828},{"date":"2024-03-08","current":-0.881508,"twenty":-4.290152,"median":-2.892646,"eighty":-0.76764,"marketCap":4052926},{"date":"2024-03-15","current":-0.873421,"twenty":-4.211677,"median":-2.875432,"eighty":-0.727851,"marketCap":4015743},{"date":"2024-03-22","current":-0.721381,"twenty":-4.136461,"median":-2.838342,"eighty":-0.725133,"marketCap":3316706},{"date":"2024-03-28","current":-1.261608,"twenty":-4.114119,"median":-2.824855,"eighty":-0.727851,"marketCap":5800518},{"date":"2024-04-05","current":-3.439365,"twenty":-4.114119,"median":-2.834438,"eighty":-0.727851,"marketCap":15988608},{"date":"2024-04-12","current":-3.935274,"twenty":-4.087122,"median":-2.8749,"eighty":-0.727851,"marketCap":18293942},{"date":"2024-04-19","current":-2.351566,"twenty":-4.003341,"median":-2.866559,"eighty":-0.748716,"marketCap":10931746},{"date":"2024-04-26","current":-2.215591,"twenty":-3.983265,"median":-2.830534,"eighty":-0.750495,"marketCap":10299638},{"date":"2024-05-03","current":-2.639513,"twenty":-3.968788,"median":-2.818741,"eighty":-0.761817,"marketCap":12270327},{"date":"2024-05-10","current":-1.855657,"twenty":-3.967268,"median":-2.818112,"eighty":-0.782844,"marketCap":8626411},{"date":"2024-05-17","current":-2.001563,"twenty":-3.952607,"median":-2.803737,"eighty":-0.792549,"marketCap":9890627},{"date":"2024-05-24","current":-1.595231,"twenty":-3.935274,"median":-2.80356,"eighty":-0.808723,"marketCap":7882755},{"date":"2024-05-31","current":-1.053454,"twenty":-3.909679,"median":-2.788653,"eighty":-0.830719,"marketCap":5205593},{"date":"2024-06-07","current":-1.083553,"twenty":-3.883526,"median":-2.768954,"eighty":-0.840101,"marketCap":5354324},{"date":"2024-06-14","current":-1.353237,"twenty":-3.84715,"median":-2.767002,"eighty":-0.866951,"marketCap":6686956},{"date":"2024-06-21","current":-2.468093,"twenty":-3.825734,"median":-2.715187,"eighty":-0.878273,"marketCap":12195961},{"date":"2024-06-28","current":-2.543339,"twenty":-3.85501,"median":-2.750143,"eighty":-0.883801,"marketCap":12567789},{"date":"2024-07-05","current":-2.763695,"twenty":-3.830253,"median":-2.748489,"eighty":-0.900328,"marketCap":13656664},{"date":"2024-07-12","current":-3.042207,"twenty":-3.814393,"median":-2.768422,"eighty":-0.923336,"marketCap":15032918},{"date":"2024-07-19","current":-2.656575,"twenty":-3.788667,"median":-2.7686,"eighty":-0.92459,"marketCap":13127336},{"date":"2024-07-26","current":-2.656575,"twenty":-3.746677,"median":-2.767002,"eighty":-0.925468,"marketCap":13127336},{"date":"2024-08-02","current":-2.335215,"twenty":-3.733029,"median":-2.724235,"eighty":-0.933966,"marketCap":11539352},{"date":"2024-08-09","current":-1.857517,"twenty":-3.730047,"median":-2.697437,"eighty":-0.951517,"marketCap":10037108},{"date":"2024-08-16","current":-1.912181,"twenty":-3.726016,"median":-2.669971,"eighty":-0.95921,"marketCap":10332484},{"date":"2024-08-23","current":-1.887789,"twenty":-3.720581,"median":-2.656575,"eighty":-0.962629,"marketCap":10200681},{"date":"2024-08-30","current":-1.804816,"twenty":-3.712993,"median":-2.640081,"eighty":-0.9702,"marketCap":9752340},{"date":"2024-09-06","current":-1.620652,"twenty":-3.707544,"median":-2.621599,"eighty":-0.974474,"marketCap":8757204},{"date":"2024-09-13","current":-1.313449,"twenty":-3.697985,"median":-2.594508,"eighty":-0.979786,"marketCap":7097231},{"date":"2024-09-20","current":-1.360078,"twenty":-3.690112,"median":-2.581967,"eighty":-0.991663,"marketCap":7349191},{"date":"2024-09-27","current":-1.383196,"twenty":-3.685938,"median":-2.548581,"eighty":-0.995169,"marketCap":7474112},{"date":"2024-10-04","current":-1.288959,"twenty":-3.672451,"median":-2.526811,"eighty":-1.004353,"marketCap":6964899},{"date":"2024-10-11","current":-1.530136,"twenty":-3.661324,"median":-2.506607,"eighty":-1.011474,"marketCap":8268104},{"date":"2024-10-18","current":-2.468594,"twenty":-3.652165,"median":-2.503042,"eighty":-1.016112,"marketCap":13339068},{"date":"2024-10-25","current":-4.486572,"twenty":-3.661324,"median":-2.525592,"eighty":-1.021413,"marketCap":24243226},{"date":"2024-11-01","current":-6.191077,"twenty":-3.697985,"median":-2.535685,"eighty":-1.032299,"marketCap":33453535},{"date":"2024-11-08","current":-8.798889,"twenty":-3.726664,"median":-2.549455,"eighty":-1.04107,"marketCap":48874099},{"date":"2024-11-15","current":-9.771398,"twenty":-3.799802,"median":-2.589694,"eighty":-1.056464,"marketCap":54275973},{"date":"2024-11-22","current":-8.845199,"twenty":-3.898342,"median":-2.594508,"eighty":-1.071514,"marketCap":49131331},{"date":"2024-11-29","current":-9.678778,"twenty":-3.967268,"median":-2.607519,"eighty":-1.083553,"marketCap":53761508},{"date":"2024-12-06","current":-10.095568,"twenty":-4.087122,"median":-2.640081,"eighty":-1.083553,"marketCap":56076597},{"date":"2024-12-13","current":-9.169369,"twenty":-4.212284,"median":-2.656575,"eighty":-1.090175,"marketCap":50931955},{"date":"2024-12-20","current":-6.089758,"twenty":-4.326829,"median":-2.668127,"eighty":-1.098726,"marketCap":33826021},{"date":"2024-12-27","current":-6.830717,"twenty":-4.457081,"median":-2.687275,"eighty":-1.111182,"marketCap":37941734},{"date":"2025-01-03","current":-7.085421,"twenty":-4.489142,"median":-2.700469,"eighty":-1.114296,"marketCap":39356511},{"date":"2025-01-10","current":-6.159222,"twenty":-4.533949,"median":-2.724235,"eighty":-1.116687,"marketCap":34211869},{"date":"2025-01-17","current":-7.316971,"twenty":-4.601166,"median":-2.767002,"eighty":-1.126594,"marketCap":40642671},{"date":"2025-01-24","current":-6.298152,"twenty":-4.653204,"median":-2.768777,"eighty":-1.140878,"marketCap":34983565},{"date":"2025-01-31","current":-6.761252,"twenty":-4.785205,"median":-2.781147,"eighty":-1.16021,"marketCap":37555886},{"date":"2025-02-07","current":-8.613649,"twenty":-4.885096,"median":-2.80356,"eighty":-1.162531,"marketCap":47845170},{"date":"2025-02-14","current":-7.664296,"twenty":-4.924468,"median":-2.803737,"eighty":-1.170895,"marketCap":42571912},{"date":"2025-02-21","current":-6.645477,"twenty":-4.933777,"median":-2.812788,"eighty":-1.175045,"marketCap":36912806},{"date":"2025-02-28","current":-6.274997,"twenty":-5.073412,"median":-2.818741,"eighty":-1.18848,"marketCap":34854949},{"date":"2025-03-07","current":-5.510883,"twenty":-5.113516,"median":-2.827694,"eighty":-1.190617,"marketCap":30610619},{"date":"2025-03-14","current":-3.759943,"twenty":-5.113516,"median":-2.858218,"eighty":-1.190617,"marketCap":28602574},{"date":"2025-03-21","current":-4.16217,"twenty":-5.073734,"median":-2.875432,"eighty":-1.191533,"marketCap":31662384},{"date":"2025-03-28","current":-3.340229,"twenty":-5.073412,"median":-2.892239,"eighty":-1.205576,"marketCap":25409728},{"date":"2025-04-04","current":-2.95549,"twenty":-5.073412,"median":-2.904166,"eighty":-1.220583,"marketCap":22482953},{"date":"2025-04-11","current":-3.2353,"twenty":-5.073412,"median":-2.908715,"eighty":-1.221146,"marketCap":24611517},{"date":"2025-04-17","current":-2.952867,"twenty":-5.036176,"median":-2.908941,"eighty":-1.222104,"marketCap":22462998},{"date":"2025-04-25","current":-3.200324,"twenty":-5.026867,"median":-2.926364,"eighty":-1.222365,"marketCap":24345447},{"date":"2025-05-02","current":-3.130372,"twenty":-5.006553,"median":-2.952867,"eighty":-1.223833,"marketCap":23813306},{"date":"2025-05-09","current":-2.863738,"twenty":-4.984552,"median":-2.926364,"eighty":-1.232277,"marketCap":21784974},{"date":"2025-05-16","current":-2.546651,"twenty":-4.943086,"median":-2.908941,"eighty":-1.235987,"marketCap":21784974},{"date":"2025-05-23","current":-2.426337,"twenty":-4.933777,"median":-2.901322,"eighty":-1.244124,"marketCap":20755762},{"date":"2025-05-30","current":-2.389627,"twenty":-4.933777,"median":-2.892443,"eighty":-1.246052,"marketCap":20441735},{"date":"2025-06-06","current":-2.389627,"twenty":-4.933777,"median":-2.885538,"eighty":-1.247409,"marketCap":20441735}],"updateTime":1749344513405}}}